SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Tracon Pharmaceuticals, Inc. (TCON)

Add TCON Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 6/16/2016 2:03:34 PM - Followers: 2 - Board type: Free - Posts Today: 0
TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases. We are a leader in the field of endoglin biology and are using our expertise to develop antibodies that bind to the endoglin receptor. Our lead product candidate, TRC105, is an anti-endoglin antibody that is being developed for the treatment of multiple solid tumor types in combination with inhibitors of the VEGF pathway. Our other product candidates are TRC205, an anti-endoglin antibody that is in preclinical development for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development for the treatment of lung cancer and glioblastoma. Each of our product candidates is expected to complement currently available therapies.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
TCON News: Current Report Filing (8-k) 10/05/2016 04:34:15 PM
TCON News: Current Report Filing (8-k) 09/28/2016 04:37:53 PM
TCON News: Quarterly Report (10-q) 08/11/2016 06:08:05 AM
TCON News: Current Report Filing (8-k) 08/10/2016 04:14:52 PM
TCON News: Current Report Filing (8-k) 07/29/2016 04:03:11 PM
#5   TCON bearish 5.25 stocktrademan 06/16/16 02:03:34 PM
#4   $TCON recent news/filings stocktrademan 09/18/15 11:30:44 AM
#3   $TCON recent news/filings stocktrademan 06/19/15 03:46:57 PM
#2   Hit $13 today. Someday more iHubbers will kick ipulator_man 04/14/15 05:13:04 PM
#1   § TCON In @ $12 § ipulator_man 04/12/15 01:40:43 AM